000753483 000__ 03121cam\a2200445Ii\4500
000753483 001__ 753483
000753483 005__ 20230306141600.0
000753483 006__ m\\\\\o\\d\\\\\\\\
000753483 007__ cr\cn\nnnunnun
000753483 008__ 160126s2016\\\\ii\a\\\\ob\\\\000\0\eng\d
000753483 019__ $$a936146490
000753483 020__ $$a9788132226079$$q(electronic book)
000753483 020__ $$a8132226070$$q(electronic book)
000753483 020__ $$z9788132226062
000753483 020__ $$z8132226062
000753483 0247_ $$a10.1007/978-81-322-2607-9$$2doi
000753483 035__ $$aSP(OCoLC)ocn936040268
000753483 035__ $$aSP(OCoLC)936040268$$z(OCoLC)936146490
000753483 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dIDEBK$$dEBLCP$$dN$T$$dYDXCP$$dAZU$$dCOO$$dOCLCF
000753483 049__ $$aISEA
000753483 050_4 $$aRS431.R34
000753483 08204 $$a615.8/42$$223
000753483 1001_ $$aKnapp, Furn F.,$$d1944-$$eauthor.
000753483 24510 $$aRadiopharmaceuticals for therapy$$h[electronic resource] /$$cF. F. (Russ) Knapp, Ashutosh Dash.
000753483 264_1 $$aNew Delhi :$$bSpringer,$$c2016.
000753483 300__ $$a1 online resource (xxiv, 347 pages) :$$billustrations.
000753483 336__ $$atext$$btxt$$2rdacontent
000753483 337__ $$acomputer$$bc$$2rdamedia
000753483 338__ $$aonline resource$$bcr$$2rdacarrier
000753483 504__ $$aIncludes bibliographical references.
000753483 506__ $$aAccess limited to authorized users.
000753483 520__ $$aThis book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
000753483 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 27, 2016).
000753483 650_0 $$aRadiopharmaceuticals.
000753483 7001_ $$aDash, Ashutosh,$$eauthor.
000753483 77608 $$iPrint version:$$z8132226062$$z9788132226062$$w(OCoLC)913557261
000753483 852__ $$bebk
000753483 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-81-322-2607-9$$zOnline Access$$91397441.1
000753483 909CO $$ooai:library.usi.edu:753483$$pGLOBAL_SET
000753483 980__ $$aEBOOK
000753483 980__ $$aBIB
000753483 982__ $$aEbook
000753483 983__ $$aOnline
000753483 994__ $$a92$$bISE